We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$3.6B
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.96% |
| 3 | Technology | 16.37% |
| 4 | Consumer Discretionary | 9.33% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
American Coastal Insurance
ACIC
$498M
| $143K | ﹤0.01% |
91,716
-45,838
| -33% | -$97.3K |
|
3202
ASE Group
ASX
$80.8B
| $142K | ﹤0.01% |
+27,367
| New | +$182K |
|
3203
Vanda Pharmaceuticals
VNDA
$312M
| $140K | ﹤0.01% |
12,818
-3,846
| -23% | -$39.9K |
|
|
FLNT
3204
Fluent
FLNT
$102M
| $139K | ﹤0.01% |
19,488
+17,250
| +771% | +$144K |
|
|
LENZ
3205
LENZ Therapeutics
LENZ
$172M
| $139K | ﹤0.01% |
+7,235
| New | +$161K |
|
|
MILEW
3206
CALL
DELISTED
Metromile, Inc. Warrant
MILEW
| $138K | ﹤0.01% |
150,000
-27,450
| -15% | -$3.98K |
|
3207
FinWise Bancorp
FINW
$189M
| $137K | ﹤0.01% |
14,774
-12,522
| -46% | -$177K |
|
|
HARP
3208
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $137K | ﹤0.01% |
+7,174
| New | +$186K |
|
|
SLVRW
3209
CALL
DELISTED
SilverSPAC Inc. Warrant
SLVRW
| $135K | ﹤0.01% |
13,996
| – | – |
|
3210
Cue Biopharma
CUE
$135M
| $134K | ﹤0.01% |
+1,799
| New | +$210K |
|
3211
Envela
ELA
$536M
| $134K | ﹤0.01% |
+18,715
| New | +$102K |
|
3212
MannKind Corp
MNKD
$1.28B
| $134K | ﹤0.01% |
35,200
-761,643
| -96% | -$2.8M |
|
|
WIMI
3213
WiMi Hologram Cloud
WIMI
$21.1M
| $134K | ﹤0.01% |
6,083
-61,741
| -91% | -$1.29M |
|
|
AGS
3214
DELISTED
PlayAGS
AGS
| $133K | ﹤0.01% |
+25,783
| New | +$150K |
|
3215
ProQR Therapeutics
PRQR
$243M
| $133K | ﹤0.01% |
+171,172
| New | +$128K |
|
3216
Bakkt Inc
BKKT
$333M
| $131K | ﹤0.01% |
+2,494
| New | +$210K |
|
|
ACB
3217
Aurora Cannabis
ACB
$165M
| $130K | ﹤0.01% |
+9,882
| New | +$247K |
|
3218
GrafTech
EAF
$194M
| $128K | ﹤0.01% |
+1,815
| New | +$158K |
|
3219
Stereotaxis
STXS
$129M
| $128K | ﹤0.01% |
+69,418
| New | +$166K |
|
|
HUT
3220
Hut 8
HUT
$12.4B
| $127K | ﹤0.01% |
19,100
+11,980
| +168% | +$179K |
|
3221
CALL
Valens Semiconductor Ltd Warrants
VLN.WS
| $126K | ﹤0.01% |
35,994
-99,083
| -73% | -$34.8K |
|
|
XNET
3222
Xunlei
XNET
$351M
| $123K | ﹤0.01% |
77,045
-362,171
| -82% | -$515K |
|
|
RDUS
3223
DELISTED
Radius Health, Inc.
RDUS
| $123K | ﹤0.01% |
11,747
-370,760
| -97% | -$2.76M |
|
|
RJET
3224
Republic Airways Holdings
RJET
$810M
| $119K | ﹤0.01% |
+3,632
| New | +$171K |
|
|
ZUO
3225
DELISTED
Zuora, Inc.
ZUO
| $119K | ﹤0.01% |
+13,300
| New | +$148K |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.